Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02039726
Title (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Daiichi Sankyo Inc.
Indications

acute myeloid leukemia

Therapies

Cytarabine + Fludarabine

Cytarabine + Etoposide + Mitoxantrone

Quizartinib

Filgrastim + Idarubicin

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST